Roche's Early Present to Halozyme
680794
Happy Holidays! Have some drug-enhancing technology.
409761
Genzyme shows some sparkle at investors' conference.
555063
NEW YORK  - Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the US Food and Drug Administration (news - web sites) (FDA (news - web sites)) for the treatment of
269183
The MOR202 antibodies were initially characterized in detail in various in vitro assays.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
28028
Genzyme Corp.&#39;s not-yet-completed $1 billion acquisition of Ilex Oncology Inc. appeared to pay off yesterday when an advisory committee to the Food and Drug
535175
BioSante releases more info on the pivotal studies for its lead drug.
763508
NEW YORK DEC 29, 2004  - Genzyme Corp. announced Wednesday that the US Food and Drug Administration (FDA) has approved the nucleoside analogue clofarabine (Clolar) for the treatment of children
134131
Doctors are pestering salespeople at drug maker Roche for samples of Tamiflu, an anti-viral flu medication made in Boulder. Boulder retailer Pharmaca is seeing a run on homeopathic remedies to stave off the flu.
505088
It will be three years before it and partner Roche evaluate results for a treatment for lupus.
375061
The drugmaker gets a step closer to starting a clinical trial for a hepatitis C drug.
93007
Kristen Galfetti&#39;s small glass office at the new headquarters of Genzyme, a producer of therapeutic drugs in Cambridge, Massachusetts, has two doors.
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
160780
Roche Holding, the world&#39;s biggest maker of diagnostic tests, has received Food and Drug Administration approval to market the first laboratory gene test that can help doctors reduce the risk of side effects for certain medications.
388102
Pre-clinical trial results are mixed, but mark a major step forward for developing human treatments.
761145
Roche has received F.D.A. approval to market the first gene test that can help doctors reduce the risk of side effects for certain medications.
394994
ST. LOUIS, Feb. 1  /PRNewswire-FirstCall/ -- Sigma-Aldrich , a leading $1.7 billion Life Science and High Technology Company, has enhanced its Bioactive Nutrient Explorer.